Phase 4 Rheumatoid Arthritis Trial, Recruiting (NCT05955066)

Phase 4 Rheumatoid Arthritis Trial, Recruiting NCT05955066 Sponsor: Chinese University of Hong Kong Condition: Rheumatoid Arthritis

Printed from Voxsanity (voxsanity.com.au) — NCT05955066 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Rheumatoid Arthritis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You have been diagnosed with rheumatoid arthritis (RA) according to recognized medical guidelines
You have been taking the medication methotrexate for at least 12 weeks
Your rheumatoid arthritis is not well controlled, based on a specific disease activity measurement called DAS28-CRP being above 3.2 (confirm with trial site)

Who may not be able to join:

You are 65 years of age or older
Your arthritis severely limits your ability to take care of yourself or carry out daily activities
You are pregnant, or you are a woman who has not yet gone through menopause and is planning to become pregnant
You have previously taken certain arthritis medications beyond methotrexate and hydroxychloroquine (confirm with trial site for a full list)
You have ever taken certain bone-strengthening medications, including bisphosphonates, denosumab, or teriparatide
You have a history of heart disease, blood clots, or cancer
You have a medical reason why you cannot take the drug baricitinib (confirm with trial site)
You have severe joint damage in certain finger joints that would prevent a special type of bone scan from being carried out (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 92786351

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05955066

Sponsor: Chinese University of Hong Kong

Phase: Phase 4

Status: Recruiting

Condition: Rheumatoid Arthritis

Trial contact: 92786351

More information: https://clinicaltrials.gov/study/NCT05955066

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You have been diagnosed with rheumatoid arthritis (RA) according to recognized medical guidelines
You have been taking the medication methotrexate for at least 12 weeks
Your rheumatoid arthritis is not well controlled, based on a specific disease activity measurement called DAS28-CRP being above 3.2 (confirm with trial site)

Who may not be able to join:

You are 65 years of age or older
Your arthritis severely limits your ability to take care of yourself or carry out daily activities
You are pregnant, or you are a woman who has not yet gone through menopause and is planning to become pregnant
You have previously taken certain arthritis medications beyond methotrexate and hydroxychloroquine (confirm with trial site for a full list)
You have ever taken certain bone-strengthening medications, including bisphosphonates, denosumab, or teriparatide
You have a history of heart disease, blood clots, or cancer
You have a medical reason why you cannot take the drug baricitinib (confirm with trial site)
You have severe joint damage in certain finger joints that would prevent a special type of bone scan from being carried out (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Chinese University of Hong Kong

Registry

ClinicalTrials.gov

Start date

1 December 2023

Est. completion

1 February 2026

Where this trial is recruiting

Hong Kong

Primary endpoints

The proportion of patients with reduction of erosion volume on HR-pQCT over 2-4 metacarpophalangeal (MCP 2-4) at 24 weeks comparing JAK inhibitor group and placebo group.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov